select a format

Single User License
USD 2995 INR 193028
Site License
USD 5990 INR 386056
Corporate User License
USD 8985 INR 579083

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Life Cycle Management Strategies-Optimizing revenues and defending generic competition

Life Cycle Management Strategies-Optimizing revenues and defending generic competition


  • Products Id :- GBI059CBR
  • |
  • Pages: 100
  • |
  • July 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Life Cycle Management Strategies-Optimizing revenues and defending generic competition GBI Research's latest report, "Life Cycle Management Strategies-Optimizing revenues and defending generic competition" discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on. Companies mentioned in the report are AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma. Scope Introduction of LCM and product life cycle Objectives of LCM and factors impacting the choice of strategies LCM strategies depending on the way of approach Impact of LCM strategies on sales and growth trend of selected products Patent term extension and market exclusivity in the US and Europe LCM strategies of pipeline drugs of key players Keys to successful implementation of LCM strategies Reasons To Buy Identify the key LCM strategies used by most of the pharmaceutical companies Analyze the strategies to increase lifecycle and revenues of a drug Gain an understanding on the implementation of multiple strategies for a single product by including case studies Understand the operational pipeline strategies of key players



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Executive Summary Introduction Overview of Product Life Cycle Product Life Cycle Curve Objectives of Life Cycle Management (LCM) Classification and Benefits of LCM Strategies Strategic Planning for LCM Factors Impacting Choice of LCM Strategies Developmental Strategies Indication Expansion/Sequencing and Repositioning Patient Subpopulations and Personalized Medicine Reformulation New Dosage Forms New Route of Administration Special Cases New Dosage Strengths and Regimen Fixed-Dose Combination and Co-packaging Next Generation Products and Modified Chemistry Metabolites Chiral Switching Polymorphs Multiple Developmental Strategy Approach Commercial Strategies Rx-to-OTC/BTC Switch Geographical Expansion Pricing Strategy and Tactics Pricing Strategy for Targeting Multiple Indications Coupons Co-pay Cards Awareness, Brand Loyalty and Service Programs Regulatory and Legal Strategies Authorized Generics Legal Defense and Pay for Delay Citizen's Petition Patent Term Extension and Market Exclusivity The Pharmaceutical Pipeline and LCM Successful Implementation of LCM Strategies Appendix

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma

Lifecycle management


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com